Insider buying last 90 days
$1.20Min 2 open-market purchases
| Filed | Insider | Type | Value |
|---|---|---|---|
| Aug 27 | Gundlach Andrew director | Purchase | $605K |
| Aug 27 | Gundlach Andrew director | Purchase | $599K |
From Form 4 filings, dated to when each was filed.
Welltower expands its Florida nursing home portfolio this week, with two acquisitions totaling three facilities each in Broward and South Florida, one for $160 million and another for $143 million, bringing its regional nursing home transactions to nine facilities including a 294-bed property in Miami. Alongside this, Welltower raised its 2026 normalized FFO and net income outlook following strong third-quarter senior housing performance. Analyst activity followed, with UBS raising its price target to $289.00 from $269.00 while maintaining a Buy rating, and JP Morgan raising its target to $273 from $260 while maintaining an Overweight rating.
WELL closes at $244.46, down 0.2%, trading above both its 50-day average of $234.54 and 200-day average of $221.46. The stock sits in the Neutral zone of the GekkoIndex at a reading of 49. Price stands 7.5% above Gekko Fair Value of $227.37.
The next earnings report is scheduled for 9 February 2027, placing it outside the typical 20-trading-day window. Over the last 90 days, 2 insider purchases totaling $1,203,825 were recorded, with no billionaire holders noted. Seasonality over this stretch has averaged a 2.4% decline across 5 years, rising in just 1 of those years. Consensus among 14 firms stands at 13 buy and 1 hold ratings, with a consensus target of $262.73.
Written by AI from the Nov 13, 2026 close and checked automatically against the figures on this page.
Welltower scores 3 supportive, 1 mixed and 2 headwinds across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed2 headwinds
Above 50 and 200-day
Close $244.46 is above the 50-day ($234.54) and 200-day ($221.46) averages, and the 50-day is above the 200-day.
See the chart49, Neutral
Reading 49 is in the Neutral zone.
See the GekkoIndex8.7% above
Price is 8.7% above Gekko Fair Value (more than 5% above).
See fair valueLeans bullish
Last 90 days: 2 open-market insider purchases.
See smart moneyReports in 86 days
Next report Feb 9, 2027, 86 days away — outside a typical 20-trading-day hold.
See earnings−2.0% on average
From this point in the calendar, the next 20 trading days averaged −2% over 5 years, rising in 1 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Welltower closed at $244.46 on Nov 13, 2026, +27.6% over the past year, inside a 52-week range of $181.47 to $255.20.
Use the left and right arrow keys to read daily values.
Put WELL on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Welltower funds and owns the buildings where healthcare and elder care actually happen, rather than delivering that care itself. It teams up with established operators who run senior living communities, rehabilitation and recovery facilities, and hospital-linked services, supplying the real estate those groups depend on.
As a real estate investment trust, Welltower makes money by acquiring and leasing out properties used for senior living, recovery care, and outpatient medical treatment. Its tenants are the operating companies that manage day-to-day care on site, and its buildings are concentrated in growing regions spread across America, Canada, and Britain.
The company is headquartered in Toledo, Ohio, and belongs to the S&P 500 index. Its stock is listed on the NYSE under the ticker WELL.
Welltower’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 49, in the Neutral zone, up 1.2 points over five sessions.
Up 1.2 points over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 11 | +2.3% | +9.0% | ||
| Accumulation | 119 | +1.4% | +6.0% | ||
| Neutral (current zone) | 474 | +0.7% | +2.8% | ||
| Distribution | 50 | +0.2% | −1.3% | ||
| Selling | 1 | Too few readings yet | |||
Average WELL share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Welltower trades 8.7% above Gekko Fair Value of $224.91, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Welltower shares are worth, recalculated every trading day.
$224.91
Gekko Fair Value, Nov 14, 2026
8.7% Overvalued
At the end of Aug 2026 the price was 0.0% above the estimate.
Insiders filed 2 open-market purchases in Welltower worth $1.20M, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
$1.20Min 2 open-market purchases
| Filed | Insider | Type | Value |
|---|---|---|---|
| Aug 27 | Gundlach Andrew director | Purchase | $605K |
| Aug 27 | Gundlach Andrew director | Purchase | $599K |
From Form 4 filings, dated to when each was filed.
No trades in WELL were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Welltower has been buying back its own shares.
From company filings.
0of the funds Gekko tracks hold WELL.
Welltower reports on Feb 9, 2027 (86 days away), and beat the EPS estimate in 5 of its last 8 reports.
Feb 9, 2027
86 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Oct 26, 2026 | $0.54 est $0.64 | $3.72B est $3.64B | −4.5% |
| Jul 27, 2026 | $1.60 est $1.55 | $3.54B est $3.40B | −3.4% |
| Apr 28, 2026 | $0.55 est $0.50 | $3.35B est $3.12B | +1.0% |
| Feb 10, 2026 | $0.55 est $0.59 | $3.18B est $2.86B | +5.4% |
| Oct 27, 2025 | $1.34 est $1.30 | $2.69B est $2.96B | +1.0% |
| Jul 28, 2025 | $1.28 est $1.22 | $2.52B est $2.72B | +2.7% |
| Apr 28, 2025 | $1.20 est $1.15 | $2.39B est $2.52B | +3.1% |
| Feb 11, 2025 | $0.34 est $0.41 | $2.22B est $2.19B | +2.4% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Welltower is $263.64, +7.8% from the last close, from 14 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 14 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 11 | UBS | $289 | +18.2% |
| Nov 10 | Morgan Stanley | $251 | +2.7% |
| Nov 10 | J.P. Morgan | $273 | +11.7% |
| Nov 9 | RBC Capital | $266 | +8.8% |
| Oct 29 | Cantor Fitzgerald | $258 | +5.5% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Welltower averaged −2.0% across the last 5 years, rising in 1 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.8% | 3 of 5 |
| Next 10 trading days | +0.6% | 3 of 5 |
| Next 15 trading days | 0.0% | 3 of 5 |
| Next 20 trading days | −2.0% | 1 of 5 |
| Next 30 trading days | −2.4% | 2 of 5 |
For scale, WELL’s typical 20-trading-day move in either direction is about 4.4%.
Welltower’s market cap is $179.3B, with a P/E ratio of 103.8 and revenue of $13.79B over the last twelve months.
Coverage of Welltower this week reads positive: 11 positive, 4 neutral and 1 negative headlines.
Welltower’s market cap is $179.3B at the Nov 13, 2026 close of $244.46, with 733.6M shares outstanding. The shares trade on a P/E ratio of 103.8.
The consensus analyst 12-month price target for Welltower is $263.64, +7.8% from the last close. Of the 14 firms that rated the stock in the last 90 days, 13 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Welltower is overvalued: the Nov 13, 2026 close of $244.46 is 8.7% above Gekko Fair Value of $224.91. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Welltower is expected to report on Feb 9, 2027 (86 days away). Analysts expect earnings of $0.71 per share on revenue of $3.88B. Welltower beat the earnings estimate in 5 of its last 8 reports, moving 2.9% on average across the report.
Welltower’s 52-week high is $255.20 and its 52-week low is $181.47; it closed at $244.46 on Nov 13, 2026, +27.6% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 6 items with data read as supportive (trend, smart money and earnings risk), 1 as mixed (gekkoindex) and 2 as headwinds (fair value and seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.